Trexquant Investment »

Cartesian Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2026-06-30 $428k 41k 10.42

More positions owned by Trexquant Investment

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Micron Technology Put Option (MU)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl C Call Option (GOOG)
Meta Platforms Cl A Call Option (META)
Intuit Call Option (INTU)
Costco Wholesale Corporation Put Option (COST)
Palantir Technologies Cl A Put Option (PLTR)
Broadcom Call Option (AVGO)
Eli Lilly & Co. Call Option (LLY)

View all positions for Trexquant Investment

Top funds holding Cartesian Therapeutics

Squarepoint Ops
BlackRock
683 Capital Management
Vanguard Capital Management
FMR
Geode Capital Management
AQR Capital Management
Millennium Management
Two Sigma Investments
Marshall Wace
UBS Group
Jupiter Topco
State Street Corporation
Privium Fund Management B.V.
Susquehanna International

View all funds holding Cartesian Therapeutics